What is the appropriate evaluation and management for a patient with elevated ferritin, increased total iron‑binding capacity (TIBC), and high transferrin saturation?

Evaluation and Management of Elevated Ferritin with High TIBC and High Transferrin Saturation

Initial Diagnostic Approach

This combination of elevated ferritin, increased TIBC, and high transferrin saturation is atypical and requires systematic evaluation to distinguish true iron overload from secondary causes of hyperferritinemia, as the pattern suggests possible hereditary hemochromatosis but the elevated TIBC is unusual for this condition. 1

First-Line Testing

The initial workup must include:

• HFE genetic testing for C282Y and H63D mutations - This is the critical first step when transferrin saturation and ferritin are both elevated, as these findings indicate possible haemochromatosis with iron overload 1, 2. The 2022 EASL guidelines strongly recommend assessment of serum iron parameters including transferrin saturation and serum ferritin as the first step in testing for haemochromatosis 1.

• Morning blood sample for iron studies - Transferrin saturation shows significant variability; samples should be taken in the morning (fasting does not improve diagnostic utility) 1.

• Liver transaminases (ALT/AST) - Elevated liver enzymes alongside elevated transferrin saturation and high ferritin are biochemical findings that indicate haemochromatosis with iron overload 1. In one study, 90% of patients with persistent non-transfusional hyperferritinemia had ALT, AST, or other abnormal values 3.

Critical Interpretation Note

The elevated TIBC in your scenario is unusual for classic iron overload states, as TIBC typically decreases or remains normal in hereditary hemochromatosis 1. This discordant finding warrants careful consideration of:

• Laboratory error or timing issues (iron studies can fluctuate significantly) 1
• Mixed pathology (concurrent iron deficiency and iron overload in different compartments)
• Secondary causes of hyperferritinemia without true iron overload 4, 5

Differential Diagnosis Based on Pattern

If HFE Testing is Positive (C282Y Homozygous or C282Y/H63D Compound Heterozygous)

• Proceed with iron overload quantification using MRI to quantify hepatic iron concentrations 1. The 2022 EASL guidelines strongly recommend MRI in patients with unclear hyperferritinemia, biochemical iron overload, or positive liver iron staining 1.

• Transferrin saturation >60% with ferritin >963 μg/L correctly identifies 95.3% of patients with severe liver iron overload (>7 mg/g) 6. This recent 2025 study provides the most precise thresholds for determining who needs immediate MRI assessment.

If HFE Testing is Negative

Evaluate for secondary iron overload causes 2:

• Hematologic disorders: Thalassemia syndromes, myelodysplastic syndrome, myelofibrosis, sideroblastic anemias, sickle cell disease, pyruvate kinase deficiency 2
• Iatrogenic causes: Blood transfusions (particularly in sickle cell disease treatment - found in 20% of cases with persistent hyperferritinemia) 3
• Chronic liver diseases: Fatty liver disease, excess alcohol consumption, metabolic syndrome 1, 2

If Iron Overload is Excluded

Investigate causes of hyperferritinemia without iron overload 2, 5:

• Chronic liver disease (ferritin is often elevated in fatty liver disease and metabolic syndrome) 1
• Malignancy (ferritin is a tumor marker) 1
• Infections and inflammatory conditions (ferritin is an acute phase reactant) 1
• Kidney failure 2
• Rheumatic conditions (adult-onset Still's disease, hemophagocytic lymphohistiocytosis) 2
• C-reactive protein should be checked to assess for inflammation 3

Management Algorithm

For Confirmed Iron Overload

Phlebotomy is the mainstay of therapy 1:

• Induction phase: Weekly phlebotomy of 450-500 mL until serum ferritin reaches 50-100 μg/L 1

• Monitor hemoglobin at each session; decrease frequency if hemoglobin <12 g/dL, discontinue if <11 g/dL 1

• Monitor ferritin monthly or after every 4th phlebotomy during induction 1

• Maintenance phase: Phlebotomy every 2-4 months to maintain ferritin 50-100 μg/L 1

• Monitor ferritin every 6 months during maintenance 1

Lifestyle Modifications (Adjunctive, Not Substitutes for Phlebotomy)

• Avoid iron supplementation and iron-fortified foods 1
• Avoid supplemental vitamin C, especially before iron depletion 1
• Limit red meat consumption 1
• Restrict alcohol intake during iron depletion; patients with cirrhosis must abstain completely 1
• Avoid raw/undercooked shellfish and seawater wound exposure (risk of Vibrio vulnificus infection in iron overload) 1

When to Refer

Refer to gastroenterology, hematology, or iron overload specialist if 5:

• Serum ferritin >1000 μg/L
• Cause of elevated ferritin remains unclear after initial workup
• Cardiac involvement suspected (consider cardiac MRI in patients with signs of heart disease) 1

Critical Pitfalls to Avoid

• Do not rely on ferritin alone - it is elevated in 90% of non-iron overload conditions 5. Ferritin is not only a marker of iron overload but also an acute phase reactant, tumor marker, and released from necrotic cells 1.

• Do not measure hepcidin - this is not recommended for diagnosis 1.

• Do not over-phlebotomize - target ferritin 50-100 μg/L, not lower, to avoid iron deficiency 1. Symptomatic iron deficiency can develop in patients with haemochromatosis if overtreated 1.

• Investigate unexpected fluctuations - significant changes in ferritin or transferrin saturation are not typical of haemochromatosis and warrant investigation for other causes 1.

• Screen first-degree relatives if hereditary hemochromatosis is confirmed - siblings have a 25% risk if the patient is C282Y homozygous 1.